Next Article in Journal
Bronchiectasis in the Last Five Years: New Developments
Next Article in Special Issue
The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
Previous Article in Journal
Diaphragm Dysfunction: Diagnostic Approaches and Management Strategies
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2016, 5(12), 114; doi:10.3390/jcm5120114

A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy

Pulmonary Hypertension Program, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, 1600 SW Archer Rd, M452, P.O. Box 100225, Gainesville, FL 32610, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Jane A. Leopold
Received: 9 September 2016 / Revised: 22 November 2016 / Accepted: 29 November 2016 / Published: 6 December 2016
(This article belongs to the Special Issue Novel Therapeutic Approaches for Pulmonary Arterial Hypertension)
View Full-Text   |   Download PDF [226 KB, uploaded 6 December 2016]

Abstract

Significant advances in the understanding of the pathophysiology of pulmonary arterial hypertension over the past two decades have led to the development of targeted therapies and improved patient outcomes. Currently, a broad armamentarium of pulmonary arterial hypertension-specific drugs exists to assist in the treatment of this complex disease state. In this manuscript, we provide a comprehensive review of the current Food and Drug Administration (FDA)-approved pulmonary arterial hypertension-specific therapies, and their supporting evidence for adults, targeting the nitric oxide, soluble guanylate cyclase, endothelin, and prostacyclin pathways. View Full-Text
Keywords: pulmonary hypertension; pulmonary arterial hypertension; nitric oxide; soluble guanylate cyclase; endothelin; prostacyclin pulmonary hypertension; pulmonary arterial hypertension; nitric oxide; soluble guanylate cyclase; endothelin; prostacyclin
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ataya, A.; Cope, J.; Alnuaimat, H. A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy. J. Clin. Med. 2016, 5, 114.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top